Rhino-Orbital and Breast Mucormycosis After COVID-19: A Case Report

Mahshid Talebi-Taher; Nahid Nafisi; Anis Ourang

doi:10.18502/jimc.v5i2.10473

Mahshid Talebi-Taher Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Nahid Nafisi Department of Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Anis Ourang Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/jimc.v5i2.10473

Keywords: COVID-19, Humans, Invasive fungal infections, Mucormycosis

Abstract

The recent rise of Invasive Fungal Infections (IFI), especially mucormycosis in COVID-19 patients, is further complicating the outcomes. Here, we present a case of concomitant rhino-orbital and breast mucormycosis after COVID-19. To the best of our knowledge, this is the first case of breast mucormycosis after COVID-19.